ROBERTSON SANFORD

Average Profitability
109.58%
Insider Buys Quantity
14
Insider Buys Sum
$5.88M
Insider Sells Quantity
16
Insider Sells Sum
$40.08M

Insider Activity of ROBERTSON SANFORD

The largest purchase of all time was on 2022-08-12 and amounted to 100000 shares of Cassava Sciences, Inc. for $2.07M.

The largest sale of all time was on 2018-09-13 and amounted to 60000 shares of Salesforce, Inc. for $9.48M.

Biography of ROBERTSON SANFORD

No biography is available at this moment.

2023-08-23PurchaseCassava Sciences, Inc.
SAVA
director
30,000
0.0716%
$17.45$523,500+23.16%
2022-08-12PurchaseCassava Sciences, Inc.
SAVA
100,000
0.253%
$20.69$2.07M+29.04%
2020-09-18PurchaseCassava Sciences, Inc.
SAVA
director
36,281
0.1287%
$8.92$323,627+341.71%
2020-09-17PurchaseCassava Sciences, Inc.
SAVA
director
213,719
0.8426%
$6.98$1.49M+527.36%
2020-08-31SaleSalesforce, Inc.
CRM
director
15,000
0.0016%
$271.87$4.08M-12.69%
2020-06-18SaleSalesforce, Inc.
CRM
director
25,000
0.0027%
$186.57$4.66M+20.69%
2019-12-20PurchaseCassava Sciences, Inc.
SAVA
director
423,788
2.2827%
$2.20$932,334+172%
2019-12-19PurchaseCassava Sciences, Inc.
SAVA
director
76,212
0.411%
$1.86$141,754+222.11%
2019-08-29SaleSalesforce, Inc.
CRM
director
25,000
0.0028%
$155.67$3.89M+5.52%
2018-09-27PurchaseCassava Sciences, Inc.
SAVA
director
37,817
0.3255%
$1.05$39,708+14.71%
2018-09-26PurchaseCassava Sciences, Inc.
SAVA
director
30,992
0.252%
$1.05$32,542+8.33%
2018-09-25PurchaseCassava Sciences, Inc.
SAVA
director
21,420
0.1809%
$1.00$21,420+18.18%
2018-09-24PurchaseCassava Sciences, Inc.
SAVA
director
9,771
0.0817%
$0.96$9,380+21.88%
2018-09-13SaleSalesforce, Inc.
CRM
director
60,000
0.0079%
$157.96$9.48M-2.67%
2018-06-11SaleSalesforce, Inc.
CRM
director
60,000
0.008%
$134.05$8.04M+11.11%
2014-07-31SaleDolby Laboratories, Inc.
DLB
director
50,118
0.0491%
$44.71$2.24M-8.99%
2014-07-30SaleDolby Laboratories, Inc.
DLB
director
73,870
0.0724%
$45.01$3.32M-9.54%
2013-11-06PurchaseCassava Sciences, Inc.
SAVA
director
31,838
0.0714%
$3.76$119,711+25.67%
2013-11-04PurchaseCassava Sciences, Inc.
SAVA
director
18,162
0.039%
$3.69$67,018+22.7%
2011-05-12SaleDolby Laboratories, Inc.
DLB
director
10,000
0.009%
$49.88$498,783-26.51%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.